Octave Bioscience Inc., of Menlo Park, Calif., said it completed a series A funding of $14 million led by BCBS Venture Partners, with participation from Echo Health Venture (a collaboration of Cambia Health Solutions and Mosaic Health Solutions), Section 32 and new as well as existing private investors.